Medical Technology

@xconomy.com 4 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

VenBio Partners Bags $394M to Back More Medicine-Making Biotechs

@xconomy.com 4 years ago

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device

@xconomy.com 4 years ago

Disc Medicine Launches With $50M to Advance New Anemia Treatments

@xconomy.com 4 years ago

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

@xconomy.com 5 years ago

Hatteras Launches New Fund With $94M for Life Science Investments

@xconomy.com 5 years ago

GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs